| Title |
Cannabinoids for epilepsy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2014
|
| DOI | 10.1002/14651858.cd009270.pub3 |
| Pubmed ID | |
| Authors |
David Gloss, Barbara Vickrey |
| Abstract |
Marijuana appears to have anti-epileptic effects in animals. It is not currently known if it is effective in patients with epilepsy. Some states in the United States of America have explicitly approved its use for epilepsy. |
X Demographics
The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 14% |
| Brazil | 2 | 7% |
| United Kingdom | 2 | 7% |
| Australia | 1 | 4% |
| Saudi Arabia | 1 | 4% |
| United States | 1 | 4% |
| Unknown | 17 | 61% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 82% |
| Practitioners (doctors, other healthcare professionals) | 5 | 18% |
Mendeley readers
The data shown below were compiled from readership statistics for 528 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | <1% |
| United Kingdom | 2 | <1% |
| Brazil | 1 | <1% |
| Puerto Rico | 1 | <1% |
| Peru | 1 | <1% |
| Unknown | 518 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 108 | 20% |
| Student > Master | 70 | 13% |
| Researcher | 68 | 13% |
| Other | 43 | 8% |
| Student > Ph. D. Student | 38 | 7% |
| Other | 91 | 17% |
| Unknown | 110 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 154 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 45 | 9% |
| Agricultural and Biological Sciences | 36 | 7% |
| Psychology | 33 | 6% |
| Neuroscience | 33 | 6% |
| Other | 96 | 18% |
| Unknown | 131 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 148. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#280,044
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#465
of 11,499 outputs
Outputs of similar age
#2,281
of 236,041 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 218 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.